Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s stock price traded down 7.8% during trading on Tuesday . The stock traded as low as $82.62 and last traded at $82.47. 11,643,962 shares traded hands during trading, a decline of 15% from the average session volume of 13,738,480 shares. The stock had previously closed at $89.44.
Analysts Set New Price Targets
TEM has been the subject of several recent analyst reports. Wolfe Research started coverage on Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price target for the company. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Bank of America increased their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. William Blair downgraded Tempus AI from an “outperform” rating to a “market perform” rating in a report on Wednesday, February 12th. Finally, TD Cowen reiterated a “buy” rating and issued a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Tempus AI has a consensus rating of “Moderate Buy” and an average target price of $58.55.
View Our Latest Stock Analysis on TEM
Tempus AI Stock Performance
Insider Buying and Selling at Tempus AI
In other news, EVP Andrew Polovin sold 51,504 shares of the company’s stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the completion of the transaction, the executive vice president now directly owns 246,085 shares of the company’s stock, valued at approximately $10,431,543.15. This represents a 17.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the transaction, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. The trade was a 2.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,583,467 shares of company stock valued at $130,542,311 over the last ninety days.
Institutional Trading of Tempus AI
Hedge funds have recently added to or reduced their stakes in the business. ARK Investment Management LLC boosted its stake in Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after buying an additional 3,141,487 shares in the last quarter. NEA Management Company LLC raised its stake in Tempus AI by 17.8% during the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after buying an additional 813,169 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. raised its holdings in Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares during the period. Finally, Franklin Resources Inc. raised its holdings in Tempus AI by 240.5% during the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock worth $93,251,000 after acquiring an additional 1,950,862 shares in the last quarter. Institutional investors own 24.22% of the company’s stock.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
- Five stocks we like better than Tempus AI
- Retail Stocks Investing, Explained
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Differences Between Momentum Investing and Long Term Investing
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- ESG Stocks, What Investors Should Know
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.